在类风湿性关节炎中甲状腺治疗失败的潜在因素:对个性化护理的影响
Ananta Srivastava1, Stefanie Au1, Sumanjali Reddy Kanmantha Reddy1
1Departments of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766 USA.
概括
在类风湿性关节炎 (RA) 患者中,甲基酸 (MTX) 的代谢是复杂的. 药物相互作用和遗传变异 (SNP) 显著影响MTX的疗效,需要个性化治疗策略以获得最佳结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性炎症疾病,需要有效的管理.
- 甲托雷克萨特 (MTX) 是 RA 的首要治疗方法,但它的疗效可能是可变的.
- 影响RA患者MTX代谢的因素需要彻底调查,以改善患者的治疗结果.
研究的目的:
- 审查和分析同时服用药物的对RA患者MTX代谢的影响.
- 调查单核酸多态 (SNPs) 在影响MTX代谢中的作用.
- 突出需要个性化治疗方法在RA管理与MTX的需要.
主要方法:
- 对RA中MTX代谢现有文献的系统综述.
- 对检查影响MTX的药物相互作用的研究进行分析.
- 探索与MTX药理动力学相关的遗传数据,特别是SNP.
主要成果:
- 组合疗法可以显著增强或损害MTX代谢.
- 特定的SNP与不同人群中不同的MTX代谢概况有关.
- 治疗失败可能需要替代治疗策略.
结论:
- 在RA中MTX代谢是多因素的,受药物相互作用和遗传背景的影响.
- 个性化医疗方法对于优化RA的MTX治疗至关重要.
- 进一步的研究是必不可少的,以充分阐明这些因素,并提高治疗结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
126
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
126
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mismatch Repair
39.8K
Overview
39.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107


